Cognitive impairments in inherited metabolic diseases: Promises and challenges

References

• Albrecht, J., Garbade, S. F., & Burgard, P. (2009). Neuropsychological speed tests and blood phenylalanine levels inpatients with phenylketonuria: A meta-analysis. Neuroscience and Biobehavioral Reviews, 33, 414–421. doi: 10.1016/j.neubiorev.2008.11.001
   PubMed Web of Science ®Google Scholar
• Anderson, P. J., & Leuzzi, V. (2010). White matter pathology in phenylketonuria. Molecular Genetics and Metabolism, 99(Suppl. 1), S3–S9. doi: 10.1016/j.ymgme.2009.10.005
   PubMed Web of Science ®Google Scholar
• Anderson, P. J., Wood, S. J., Francis, D. E., Coleman, L., Anderson, V., & Boneh, A. (2007). Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Developmental Neuropsychology, 32, 645–668. doi: 10.1080/87565640701375963
   PubMed Web of Science ®Google Scholar
• Antshel, K. M., Epstein, I. O., & Waisbren, E. (2004). Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: A descriptive study. Neuropsychology, 18, 658–664. doi: 10.1037/0894-4105.18.4.658
   PubMed Web of Science ®Google Scholar
• Bendadi, F., De Koning, T. J., Visser, G., Prinsen, H. C., De Sain, M. G., Verhoeven-Duif, N., … Van Hasselt, P. M. (2014). Impaired cognitive functioning I patients with tyrosinemia type I receiving nitisinone. The Journal of Pediatrics, 164, 398–401. doi: 10.1016/j.jpeds.2013.10.001
   PubMed Web of Science ®Google Scholar
• Bergeron, D., Poulin, S., & Laforce, R. (2018). Cognition and anatomy of adult Niemann-Pick disease type C: Insights for the Alzheimer field. Cognitive Neuropsychology.
   PubMed Web of Science ®Google Scholar
• Biegstraaten, M., Wesnes, K. A., Luzy, C., Petakov, M., Mrsic, M., Niederau, C., … van Schaik, I. N. (2012). The cognitive profile of type 1 Gaucher disease patients. Journal of Inherited Metabolic Disease, 35(6), 1093–1099. doi: 10.1007/s10545-012-9460-7
   PubMed Web of Science ®Google Scholar
• Bisiacchi, P., Tarantino, V., Mento, G., & Burlina, A. (2018). Subclinical executive function impairment in children with asymptomatic, treated phenylketonuria: A comparison with children with immunodeficiency Virus. Cognitive Neuropsychology.
   PubMed Web of Science ®Google Scholar
• Blundell, J., Frisson, S., Chakrapani, A., Kearney, S., Vijay, S., MacDonald, A., … Olson, A. (2018). Markers of cognitive function in patients with metabolic disease: Morquio syndrome and tyrosinemia type III. Cognitive Neuropsychology.
   PubMed Web of Science ®Google Scholar
• Crowe, L., Yaplito-Lee, Y., Anderson, V., & Peters, H. (2017). Cognitive and behaviour profiles of children with mucopolysaccharidosis type II. Cognitive Neuropsychology, 34(6), 347–356. doi: 10.1080/02643294.2017.1401530
   PubMed Web of Science ®Google Scholar
• Davies, E. H., Seunarine, K. K., Banks, T., Clark, C. A., & Vellodi, A. (2011). Brain white matter abnormalities in paediatric Gaucher type I and type III using diffusion tensor imaging. Journal of Inherited Metabolic Disease, 34(2), 549–553. doi: 10.1007/s10545-011-9288-6
   PubMed Web of Science ®Google Scholar
• De Felice, S., Romani, C., Geberhiwot, T., MacDonald, A., & Palermo, L. (2018). Language processing and executive functions in early treated adults with PKU. Cognitive Neuropsychology.
   PubMed Web of Science ®Google Scholar
• Garey, L. J. (2006). Brodmann's localisation in the cerebral cortex. New York: Springer.
   Google Scholar
• Goker-Alpan, O., Wiggs, E. A., Eblan, M. J., Benko, W., Ziegler, S. G., Sidransky, E., & Schiffmann, R. (2008). Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease. The Journal of Pediatrics, 153, 89–94. doi: 10.1016/j.jpeds.2007.12.023
   PubMed Web of Science ®Google Scholar
• Heilbronner, R. L., Sweet, J. J., Attix, D. K., Krull, K. R., Henry, G. K., & Hart, R. P. (2010). Official position of the American academy of clinical neuropsychology on serial neuropsychological assessments: The utility and challenges of repeat test administrations in clinical and forensic contexts. The Clinical Neuropsychologist, 24, 1267–1278. doi: 10.1080/13854046.2010.526785
   PubMed Web of Science ®Google Scholar
• Heitz, C., Epelbaum, S., & Nadjar, Y. (2017). Cognitive impairment profile in adult patients with Niemann pick type C disease. Orphanet Journal of Rare Diseases, 12, 16. doi: 10.1186/s13023-017-0714-1
   PubMed Web of Science ®Google Scholar
• Jenkins, L., Myerson, J., Joerding, J. A., & Hale, S. (2000). Converging evidence that visuospatial cognition is more age-sensitive than verbal cognition. Psychology and Aging, 15, 157–175. doi: 10.1037/0882-7974.15.1.157
   PubMed Web of Science ®Google Scholar
• Kerchner, G., Racine, C., Hale, S., Wilheim, R., Laluz, V., Miller, B., & Kramer, J. (2012). Cognitive processing speed in older adults: Relationship with white matter integrity. PloS one, 7, 1–10. doi: 10.1371/journal.pone.0050425
   Web of Science ®Google Scholar
• Landvogt, C., Mengel, E., Bartenstein, P., Buchholz, H. G., Schreckenberger, M., Siessmeier, T., … Ullrich, K. (2008). Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria. Journal of Cerebral Blood Flow & Metabolism, 28, 824–831. doi: 10.1038/sj.jcbfm.9600571
   PubMed Web of Science ®Google Scholar
• Lewis, F. M., Coman, D. J., Syrmis, M., Kilcoyne, S., & Murdoch, B. E. (2013). Differential phonological awareness skills in children with classic galactosemia: A descriptive study of four cases. JIMD Reports, 10, 45–52. doi: 10.1007/8904_2012_200
   PubMedGoogle Scholar
• McCaffrey, R. J., & Westervelt, H. J. (1995). Issues associated with repeated neuropsychological assessments. Neuropsychology Review, 5, 203–221. doi: 10.1007/BF02214762
   PubMed Web of Science ®Google Scholar
• Palermo, L., Geberhiwot, T., MacDonald, A., Limback, E., Hall, S. K., & Romani, C. (2017). Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains. Neuropsychology, 31(3), 255–267. doi: 10.1037/neu0000337
   PubMed Web of Science ®Google Scholar
• Potter, N. L., Lazarus, J. A. C., Johnson, J. M., Steiner, R. D., & Shriberg, L. D. (2008). Correlates of language impairment in children with galactosaemia. Journal of Inherited Metabolic Disease, 31, 524–532. doi: 10.1007/s10545-008-0877-y
   PubMed Web of Science ®Google Scholar
• Rapp, B. (2001). The handbook of cognitive neuropsychology: What deficits reveal about the human mind. Philadelphia, PA: Psychology Press.
   Google Scholar
• Robertson, A., Singh, R. H., Guerrero, N. V., Hundley, M., & Elsas, L. J. (2000). Outcomes analysis of verbal dyspraxia in classic galactosemia. Genetics in Medicine, 2, 142–148. doi: 10.1097/00125817-200003000-00005
   PubMed Web of Science ®Google Scholar
• Romani, C., MacDonald, A., De Felice, S., & Palermo, L. (2018). Speed of processing in early-treated adults with phenylketonuria (PKU): Quick in finding the word, but not the ladybird. Cognitive Neuropsychology, 1–28. Advance online publication. doi: 10.1080/02643294.2017.1320278
   PubMed Web of Science ®Google Scholar
• Romani, C., Palermo, L., MacDonald, A., Limback, E., Hall, S. K., & Geberhiwot, T. (2017). The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.. Neuropsychology, 31(3), 242–254. doi: 10.1037/neu0000336
   PubMed Web of Science ®Google Scholar
• Salinsky, M. C., Storzbach, D., Dodrill, C. B., & Binder, L. M. (2001). Test-retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12-16-week period. Journal of the International Neuropsychological Society, 7, 597–605. doi: 10.1017/S1355617701755075
   PubMed Web of Science ®Google Scholar
• Shallice, T. (2009). From neuropsychology to mental structure. Cambridge: Cambridge University Press.
   Google Scholar
• Thimm, E., Herebian, D., Assmann, B., Klee, D., Mayatepek, E., & Spiekerkoetter, U. (2011). Increase of CSF tyrosine and impaired serotonin turnover in tyrosinemia type I. Molecular Genetics and Metabolism, 102, 122–125. doi: 10.1016/j.ymgme.2010.11.003
   PubMed Web of Science ®Google Scholar
• Thimm, E., Richter-Werkle, R., Kamp, G., Molke, B., Herebian, D., Klee, D., … Spiekerkoetter, U. (2012). Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC. Journal of Inherited Metabolic Disease, 35(2), 263–268. doi: 10.1007/s10545-011-9394-5
   PubMed Web of Science ®Google Scholar
• Timmers, I, Jansma, B. M, & Rubio-Gozalbo, M. E. (2012). From mind to mouth: Event related potentials of sentence production in classic galactosemia. PLoS One, 12, e52826. doi: 10.1371/journal.pone.0052826
   Web of Science ®Google Scholar
• Timmers, I., Zhang, H., Bastiani, M., Jansma, B. M., Roebroeck, A., & Rubio-Gozalbo, M. E. (2015). White matter microstructure pathology in classic galactosemia revealed by neurite orientation dispersion and density imaging. Journal of Inherited Metabolic Disease, 38, 295–304. doi: 10.1007/s10545-014-9780-x
   PubMed Web of Science ®Google Scholar
• Waisbren, S. E., Potter, N. L., Gordon, C. M., Green, R. C., Greenstein, P., Gubbels, C. S., … Berry, G. T. (2012). The adult galactosemic phenotype. Journal of Inherited Metabolic Disease, 35, 279–286. doi: 10.1007/s10545-011-9372-y
   PubMed Web of Science ®Google Scholar
• Webb, A. L., Singh, R. H., Kennedy, M. J., & Elsas, L. J. (2003). Verbal dyspraxia and galactosemia. Pediatric Research, 53, 396–402. doi: 10.1203/01.PDR.0000049666.19532.1B
   PubMed Web of Science ®Google Scholar
• Wong, K., Sidransky, E., Verma, A., Mixon, T., Sandberg, G. D., Wakefield, L. K., … Schiffmann, R. (2004). Neuropathology provides clues to the pathophysiology of Gaucher disease. Molecular Genetics and Metabolism, 82, 192–207. doi: 10.1016/j.ymgme.2004.04.011
   PubMed Web of Science ®Google Scholar